Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.
about
Will there ever be a universal Staphylococcus aureus vaccine?Staphylococcus aureus Pore-Forming Toxins.Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection modelBacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins.The bicomponent pore-forming leucocidins of Staphylococcus aureusProduction of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection.The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsSingle-copy vectors for integration at the SaPI1 attachment site for Staphylococcus aureus.Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community householdsCytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond.Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.Pseudomonas aeruginosa infection augments inflammation through miR-301b repression of c-Myb-mediated immune activation and infiltration.Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy.Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.Genome sequencing unveils a novel sea enterotoxin-carrying PVL phage in Staphylococcus aureus ST772 from India.Prevalence of enterotoxins and toxin gene profiles of Staphylococcus aureus isolates recovered from a bakery involved in a second staphylococcal food poisoning occurrence.Deciphering the Pathological Role of Staphylococcal α-Toxin and Panton-Valentine Leukocidin Using a Novel Ex Vivo Human Skin Model.Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca2+mobilization by human neutrophilsEvidence of latent molecular diversity determining the virulence of community-associated MRSA USA300 clones in mice
P2860
Q26824837-9CCBB458-CDAF-457E-92F3-1AA4DEC28DDEQ30152755-DB6E59D7-BEA2-4ABA-8B33-E7BD504A2D5CQ30571941-655CD61B-6824-4148-B2C0-D1F098410BE6Q31111609-D01A508C-B42C-4E31-8399-2F50101FE9E1Q33743499-482C4E2C-64BC-439C-A77C-3402287AE999Q34075795-24B3AD9B-668A-441E-A182-8520BBE9D894Q34495209-D22788B1-7F74-45F5-8D58-D2BB390C3C51Q35137853-F5DB4A2E-1078-4D3C-B46B-1831B66BA227Q36035535-DA58A50D-A40E-43DF-8451-C398DAF13440Q36525045-D5F2DD6B-B37A-432C-AA40-054068191DCCQ36812827-966A51C8-FB79-4389-BFAF-B82D73EE6CC2Q36896790-5A459A33-99B2-4122-9E8D-9811C9617AE2Q36967664-738CAB4D-20E3-4E9A-AE84-8357D21F6AF9Q36979233-2AAC398E-BF9D-4C14-85D6-B0CF591EA4D8Q37334199-FFF0CB95-1A78-4384-96F4-A47E2FA855F1Q38193690-2534A38F-796E-485D-ADA1-5F1C6C5CB6D8Q39264668-F1A49AD9-B4F2-43FA-BDA6-E3CFECEB9B29Q39353916-487BFEF9-265E-41D0-9552-096639C01F51Q42211068-B93E328B-77A6-4967-B0C5-414154F13C5BQ54999129-DD7E7712-D75F-4A13-B235-A99490555B44Q57823983-F5F8EAFE-E0D5-4F4E-8E1E-8FD88077516FQ58795171-BB531804-2779-4C2B-8760-DB870B937FD0
P2860
Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@ast
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@en
type
label
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@ast
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@en
prefLabel
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@ast
Immune-activating properties o ...... aphylococcus aureus pneumonia.
@en
P2860
P356
P1476
Immune-activating properties o ...... taphylococcus aureus pneumonia
@en
P2093
Pauline Yoong
P2860
P304
P356
10.1128/IAI.06360-11
P407
P50
P577
2012-06-04T00:00:00Z